Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting
In a high-burden setting in The Gambia, a prospective household cohort study revealed that mucosal IgA antibodies against the pre-fusion F protein are the strongest predictor of protection against RSV infection, outperforming serum IgG and highlighting the need for vaccines that elicit robust mucosal immunity.